Redmile Group as of June 30, 2019
Portfolio Holdings for Redmile Group
Redmile Group holds 80 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 11.5 | $406M | 8.8M | 46.33 | |
| Amicus Therapeutics (FOLD) | 8.0 | $285M | 23M | 12.48 | |
| Fate Therapeutics (FATE) | 6.0 | $210M | 10M | 20.30 | |
| Argenx Se Sponsored Adr (ARGX) | 4.3 | $151M | 1.1M | 141.58 | |
| Uniqure Nv SHS (QURE) | 3.7 | $131M | 1.7M | 78.15 | |
| Audentes Therapeutics | 3.2 | $113M | 3.0M | 37.86 | |
| Epizyme | 3.1 | $110M | 8.7M | 12.55 | |
| Allakos | 2.8 | $100M | 2.3M | 43.33 | |
| Alder Biopharmaceuticals | 2.7 | $97M | 8.2M | 11.77 | |
| Atara Biotherapeutics | 2.6 | $93M | 4.6M | 20.11 | |
| Tricida | 2.2 | $77M | 1.9M | 39.46 | |
| eHealth (EHTH) | 2.2 | $77M | 889k | 86.10 | |
| Bristol Myers Squibb (BMY) | 2.1 | $76M | 1.7M | 45.35 | |
| Tandem Diabetes Care Com New (TNDM) | 2.1 | $75M | 1.2M | 64.52 | |
| Regenxbio Inc equity us cm (RGNX) | 2.0 | $72M | 1.4M | 51.37 | |
| Wave Life Sciences SHS (WVE) | 2.0 | $71M | 2.7M | 26.09 | |
| Wright Med Group N V Ord Shs | 2.0 | $71M | 2.4M | 29.82 | |
| Xencor (XNCR) | 1.9 | $66M | 1.6M | 40.93 | |
| Sarepta Therapeutics (SRPT) | 1.8 | $63M | 412k | 151.95 | |
| Anthem (ELV) | 1.5 | $52M | 184k | 282.21 | |
| Celgene Corporation | 1.5 | $52M | 557k | 92.44 | |
| Clovis Oncology | 1.5 | $52M | 3.5M | 14.87 | |
| Array Biopharma Note 2.625%12/0 (Principal) | 1.4 | $50M | 17M | 3.04 | |
| Deciphera Pharmaceuticals | 1.4 | $50M | 2.2M | 22.55 | |
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $46M | 2.9M | 15.86 | |
| Krystal Biotech (KRYS) | 1.2 | $44M | 1.1M | 40.27 | |
| Centene Corporation (CNC) | 1.0 | $36M | 691k | 52.44 | |
| Gritstone Oncology Ord (GRTSQ) | 1.0 | $36M | 3.2M | 11.14 | |
| UnitedHealth (UNH) | 1.0 | $35M | 142k | 244.01 | |
| Anaptysbio Inc Common (ANAB) | 1.0 | $34M | 610k | 56.42 | |
| Xeris Pharmaceuticals | 1.0 | $34M | 3.0M | 11.44 | |
| Syros Pharmaceuticals | 0.9 | $34M | 3.6M | 9.26 | |
| Axonics Modulation Technolog (AXNX) | 0.9 | $33M | 814k | 40.97 | |
| Replimune Group (REPL) | 0.9 | $32M | 2.2M | 14.66 | |
| Teladoc (TDOC) | 0.9 | $31M | 462k | 66.41 | |
| Livanova SHS (LIVN) | 0.9 | $31M | 424k | 71.96 | |
| ImmunoGen | 0.9 | $30M | 14M | 2.17 | |
| Stoke Therapeutics (STOK) | 0.8 | $30M | 1.0M | 29.17 | |
| Eidos Therapeutics | 0.8 | $27M | 878k | 31.08 | |
| Odonate Therapeutics Ord | 0.8 | $27M | 741k | 36.69 | |
| Dex (DXCM) | 0.7 | $26M | 172k | 149.84 | |
| Tcr2 Therapeutics Inc cs | 0.7 | $26M | 1.8M | 14.31 | |
| Oxford Immunotec Global Ord Shs | 0.7 | $25M | 1.8M | 13.76 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.7 | $24M | 168k | 142.56 | |
| Glycomimetics | 0.7 | $24M | 2.0M | 11.92 | |
| Alder Biopharmaceuticals Note 2.500% 2/0 (Principal) | 0.7 | $23M | 25M | 0.93 | |
| Cymabay Therapeutics | 0.6 | $23M | 3.1M | 7.16 | |
| Akero Therapeutics (AKRO) | 0.6 | $22M | 1.2M | 19.15 | |
| Vapotherm | 0.6 | $22M | 960k | 23.00 | |
| Atreca Cl A Com (BCEL) | 0.6 | $22M | 1.1M | 18.84 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.6 | $21M | 425k | 48.30 | |
| Morphosys Sponsored Ads (MOR) | 0.5 | $18M | 734k | 24.14 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $17M | 197k | 85.65 | |
| Chimerix (CMRX) | 0.4 | $15M | 3.6M | 4.32 | |
| Hookipa Pharma Inc equity | 0.4 | $13M | 1.9M | 6.73 | |
| Personalis Ord (PSNL) | 0.3 | $11M | 400k | 27.15 | |
| Logicbio Therapeutics | 0.3 | $11M | 815k | 13.00 | |
| Global Blood Therapeutics In | 0.3 | $9.9M | 188k | 52.60 | |
| G1 Therapeutics | 0.3 | $9.0M | 293k | 30.66 | |
| Invitae (NVTAQ) | 0.2 | $8.8M | 375k | 23.50 | |
| Principia Biopharma | 0.2 | $8.1M | 244k | 33.19 | |
| Gossamer Bio (GOSS) | 0.2 | $5.5M | 249k | 22.18 | |
| Beigene Sponsored Adr (ONC) | 0.1 | $4.9M | 40k | 123.96 | |
| Avedro | 0.1 | $4.2M | 216k | 19.64 | |
| Forty Seven | 0.1 | $2.5M | 234k | 10.60 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.4M | 738k | 1.85 | |
| Jounce Therapeutics | 0.0 | $1.3M | 255k | 4.95 | |
| Endologix Com New | 0.0 | $570k | 79k | 7.24 | |
| Vericel (VCEL) | 0.0 | $316k | 17k | 18.90 | |
| Myokardia | 0.0 | $313k | 6.3k | 50.06 | |
| Amedisys (AMED) | 0.0 | $282k | 2.3k | 121.55 | |
| Horizon Therapeutics Pub SHS | 0.0 | $274k | 11k | 24.04 | |
| Flexion Therapeutics | 0.0 | $266k | 22k | 12.30 | |
| Adverum Biotechnologies | 0.0 | $264k | 22k | 11.87 | |
| LHC | 0.0 | $259k | 2.2k | 119.58 | |
| Neurocrine Biosciences (NBIX) | 0.0 | $231k | 2.7k | 84.31 | |
| Nevro (NVRO) | 0.0 | $220k | 3.4k | 64.71 | |
| Establishment Labs Holdings Ord (ESTA) | 0.0 | $220k | 10k | 22.00 | |
| Viking Therapeutics (VKTX) | 0.0 | $135k | 16k | 8.30 | |
| Castlight Health CL B | 0.0 | $33k | 10k | 3.23 |
